Your session is about to expire
← Back to Search
Other
SEDA for Hearing Loss
N/A
Recruiting
Led By David M. Landsberger
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
At least 12 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to year 2 (completion of experiment 1.2)
Awards & highlights
Study Summary
This trial tests how well a noise reduction algorithm can help cochlear implant users ages 12+ understand speech better in different sound environments.
Who is the study for?
This trial is for cochlear implant users who are at least 12 years old and have been using their implant for over six months. Participants must be post-lingually deafened, meaning they lost hearing after acquiring language skills, and considered able to complete the study by the principal investigator.Check my eligibility
What is being tested?
The trial is testing a new noise reduction algorithm called SEDA in various listening environments. The goal is to see if it helps people with cochlear implants understand speech better when there's background noise.See study design
What are the potential side effects?
Since this trial involves a software algorithm rather than medication or invasive procedures, traditional side effects are not expected. However, participants may experience fatigue or frustration during testing.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 12 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to year 2 (completion of experiment 1.2)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to year 2 (completion of experiment 1.2)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percent of Words Correctly Recognized in Noisy Conditions with Clinical NR
Percent of Words Correctly Recognized in Noisy Conditions with SEDA NR
Percent of Words Correctly Recognized in Noisy Conditions without NR
+8 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Cochlear Implant UsersExperimental Treatment1 Intervention
Participants will complete up to 4 experiments evaluating the use of the Speech Enhancement using Dynamic thresholding Approach (SEDA) algorithm. Each testing session will take between 4-6 hours to complete. Testing sessions will continue until the completion of the experiments.
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,369 Previous Clinical Trials
840,538 Total Patients Enrolled
15 Trials studying Hearing Loss
2,350 Patients Enrolled for Hearing Loss
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
330 Previous Clinical Trials
178,411 Total Patients Enrolled
56 Trials studying Hearing Loss
20,093 Patients Enrolled for Hearing Loss
David M. LandsbergerPrincipal InvestigatorNYU Langone Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not use a cochlear implant and am 12 years old or older.You have received a cochlear implant and have had at least 6 months of experience, no matter which company made the implant.The doctor thinks I can understand and do the study tasks.I am 12 years old or older.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Cochlear Implant Users
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the current recruitment size of this research program?
"Affirmative. Information from clinicaltrials.gov states that the medical trial is currently recruiting patients, with 60 individuals being sought after at a single recruitment centre since it was posted on March 1st 2023 and updated lastly on 23rd of March 2023."
Answered by AI
Is enrollment still possible in this trial?
"Affirmative. According to the documentation on clinicaltrials.gov, this medical trial is currently enlisting participants. It was originally published on March 1st 2023 and has been revised most recently on March 23rd of the same year. Sixty individuals are sought from a single medical centre for participation in the study."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger